Showing results (1431-1440 of 1,498) with videos related to
Sort By:
Pageof 150
Mabs|December 9, 2024
A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancerPeter Jung, Stefan P Glaser, Jing Han, et al.European Heart Journal. Cardiovascular Imaging|October 1, 2019
Cardiovascular risk scoring and magnetic resonance imaging detected subclinical cerebrovascular diseaseSonia S Anand, Jack V Tu, Dipika Desai, et al.European Heart Journal|August 22, 2020
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)Matteo Serenelli, Michael Böhm, Silvio E Inzucchi, et al.Molecular Cancer Therapeutics|April 26, 2024
HPN328, a Trispecific T Cell-Activating Protein Construct Targeting DLL3-Expressing Solid TumorsMary E Molloy, Wade H Aaron, Manasi Barath, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 28, 2021
Cardiac biomarkers retain prognostic significance in patients with heart failure and chronic obstructive pulmonary diseaseGiuseppe Vergaro, Alberto Aimo, James L Januzzi, et al.The Lancet. Diabetes & Endocrinology|September 3, 2017
Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE studyAndrew Mente, Mahshid Dehghan, Sumathy Rangarajan, et al.Lancet (London, England)|November 15, 2017
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trialStuart J Connolly, John W Eikelboom, Jackie Bosch, et al.Neurology|February 14, 2024
Incidence of Stroke in Indigenous Populations of Countries With a Very High Human Development Index: A Systematic ReviewAnna H Balabanski, Angela Dos Santos, John A Woods, et al.Plos Medicine|February 25, 2012
Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication biasRobert Clarke, Derrick A Bennett, Sarah Parish, et al.The Lancet. Respiratory Medicine|October 13, 2022
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trialJohn W Eikelboom, Sanjit S Jolly, Emilie P Belley-Cote, et al.Pageof 150